HIV感染者感染COVID-19后主要心血管事件风险
基于加泰罗尼亚PISCIS HIV队列的匹配队列研究,纳入4199例感染COVID-19的PWH与14004例未感染者,中位随访243天。COVID-19与后续主要心血管事件风险升高相关(校正HR 1.30,95%CI 1.09-1.55),仅纳入无既往心血管病者(1.60,95%CI 1.11-2.29)或未住院者(1.34,95%CI 1.11-1.62)时仍相关。
要点
- COVID-19后PWH主要心血管事件累积发生率在首年高于未感染者(log-rank P=0.011)。
- 校正分析显示COVID-19与后续心血管事件风险升高相关,校正HR 1.30(95%CI 1.09-1.55)。
- 仅纳入无既往心血管病者(校正HR 1.60)或未住院者(校正HR 1.34)时该关联仍存在。
核心结论
- 作者认为COVID-19与PWH后续一年内主要心血管事件风险增加30%相关,提示短期内应将COVID-19视为PWH的额外心血管病风险。
研究设计与样本
- 基于人群的匹配队列研究,纳入加泰罗尼亚PISCIS HIV队列中所有≥16岁的PWH,比较感染与未感染COVID-19者COVID-19后首次心血管事件(复合结局,2020-2022年)的发生率。
- 采用逆概率加权校正基线差异,并使用竞争风险分析。
- 共纳入4199例感染COVID-19的PWH和14004例未感染的PWH;中位随访243天(四分位距93-455天),82%(14941/18203)为男性,中位年龄47岁。
主要发现
- 感染COVID-19的PWH中211例、未感染者中621例发生心血管事件,发生率分别为70.2/1000人年和56.8/1000人年。
- 感染COVID-19期间,7.6%(320/4199)需住院、0.6%(25/4199)需重症监护病房;97%(4079/4199)CD4+T细胞≥200 cells/μL,90%(3791/4199)HIV-RNA<50 copies/mL,11.8%(496/4199)基线有既往心血管事件。
- COVID-19后PWH首年心血管事件累积发生率高于未感染者(log-rank P=0.011)。
- 多因素分析显示年龄、异性恋男性、既往心血管病及慢性肾或肝病与心血管事件风险显著升高相关。
- COVID-19与后续心血管事件风险升高相关(校正HR 1.30,95%CI 1.09-1.55);仅纳入无既往心血管病者时为1.60(95%CI 1.11-2.29),仅纳入未住院患者时为1.34(95%CI 1.11-1.62)。
临床怎么用
- 作者认为短期内应将COVID-19视为PWH的额外心血管病风险。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the effect of COVID-19 on the postacute risk of cardiovascular events (CVEs) among people with HIV (PWH). METHODS: Population-based matched cohort, including all PWH ≥16 years in the Catalan PISCIS HIV cohort. We estimated the incidence rate of the first CVE after COVID-19, analysed it a composite outcome (2020-2022). We adjusted for baseline differences using inverse probability weighting and used competing risk analysis. RESULTS: We included 4199 PWH with and 14 004 PWH without COVID-19. The median follow-up was 243 days (interquartile range [IQR]: 93-455), 82% (14 941/18 203) were men, with a median age of 47 years. Overall, 211 PWH with COVID-19 and 621 without developed CVE, with an incidence rate of 70.2 and 56.8/1000 person-years, respectively. During COVID-19 infection, 7.6% (320/4199) required hospitalization and 0.6% (25/4199) intensive care unit admission, 97% (4079/4199) had CD4+T-cell ≥200 cells/μL, 90% (3791/4199) had HIV-RNA<50 copies/mL and 11.8% (496/4199) had previous CVE at baseline. The cumulative CVE incidence was higher among PWH after COVID-19 compared with PWH without COVID-19 during the first year (log-rank p=0.011). The multivariable analysis identified significantly increased CVE risk with age, heterosexual men, previous cardiovascular disease (CVD), and chronic kidney or liver disease. COVID-19 was associated with increased subsequent risk of CVE (adjusted hazard ratio 1.30 [95% CI, 1.09-1.55]), also when only including individuals without previous CVD (1.60 [95% CI, 1.11-2.29]) or nonhospitalized patients (1.34 [95% CI, 1.11-1.62]). DISCUSSION: COVID-19 was associated with a 30% increased risk of major CVE in PWH during the subsequent year, suggesting that COVID-19 should be considered an additional CVD risk in PWH in the short term.
引用
- Martín-Iguacel R, Moreno-Fornés S, Bruguera A, et al. Major cardiovascular events after COVID-19 in people with HIV. Clin Microbiol Infect. 2024. PMID: 38342439. doi:10.1016/j.cmi.2024.02.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。